Published in Prog Med Virol on January 01, 1966
Replication of the parvovirus MVM. I. Dependence of virus multiplication and plaque formation on cell growth. J Virol (1972) 3.45
Factors influencing the enhancement of the infectivity of poliovirus ribonucleic acid by diethylaminoethyl-dextran. J Virol (1967) 2.95
Binding of Sindbis virus to cell surface heparan sulfate. J Virol (1998) 2.82
Enhancing effect of diethylaminoethyl-dextran on the focus-forming titer of a murine sarcoma virus (Harvey strain). J Virol (1968) 2.35
Mechanism of enhancement of virus plaques by cationic polymers. J Virol (1968) 2.02
Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation. J Virol (2000) 1.69
Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol (2002) 1.45
Development of poliovirus having increased resistance to chlorine inactivation. Appl Environ Microbiol (1977) 1.38
Polysaccharides as antiviral agents: antiviral activity of carrageenan. Antimicrob Agents Chemother (1987) 1.31
Simian rotavirus SA-11 plaque formation in the presence of trypsin. J Clin Microbiol (1979) 1.30
Parainfluenza 3 virus: plaque-type variants lacking neuraminidase activity. Infect Immun (1981) 1.25
Plaque formation by mumps virus and inhibition by antiserum. Appl Microbiol (1970) 1.17
Comparative studies of plaque variantes derived from a Florida strain of Venezuelan equine encephlomyelitis virus. Infect Immun (1972) 1.00
Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis. J Virol (1999) 0.98
The effect of diethylaminoethyl dextran and agar overlay pH on plaque formation by two plaque-size variants of foot-and-mouth disease virus. Can J Comp Med (1970) 0.87
Further studies of the physical and metabolic properties of foot-and-mouth disease virus temperature-sensitive mutants. Infect Immun (1976) 0.85
Gamma ray-induced small plaque mutants of western equine encephalitis virus. J Virol (1973) 0.84
Anti-viral Effect of Bifidobacterium adolescentis against Noroviruses. Front Microbiol (2016) 0.76
Isolation and Characterization of a Glycosyl Hydrolase Family 16 β-Agarase from a Mangrove Soil Metagenomic Library. Int J Mol Sci (2016) 0.75
Small-plaque variant of canine herpesvirus with reduced pathogenicity for newborn pups. Infect Immun (1978) 0.75
Mutants of simian virus 40 differing in plaque size, oncogenicity, and heat sensitivity. J Bacteriol (1966) 6.41
Human papovavirus, BK strain: biological studies including antigenic relationship to simian virus 40. J Virol (1973) 2.54
Enhanced growth of a murine coronavirus in transformed mouse cells. Infect Immun (1972) 2.35
Physical map of the BK virus genome. J Virol (1975) 2.18
Recovery of SV40 virus with genetic markers of original inducing virus from SV40-transformed mouse cells. Virology (1968) 2.15
The effect of interferon on SV-40 T antigen production in SV-40-transformed cells. Virology (1967) 2.13
Patterns of simian virus 40 deoxyribonucleic acid transcription. II. In transformed cells. J Virol (1973) 2.04
Isolation of papovavirus from brain tumor and urine of a patient with Wiskott-Aldrich syndrome. J Natl Cancer Inst (1974) 2.00
Site of host restriction of simian virus 40 mutants in an established African green monkey kidney cell line. J Virol (1969) 1.86
Polyoma T antigen synthesis by temperature-sensitive mutants of polyoma virus. Virology (1972) 1.84
Transformation of hamster kidney cells by BK papovavirus DNA. J Virol (1975) 1.81
Characterization of human papovavirus BK DNA. J Virol (1975) 1.81
Homology and relationship between the genomes of papovaviruses, BK virus and simian virus 40. Proc Natl Acad Sci U S A (1975) 1.81
Comparison of two human papovaviruses with simian virus 40 by structural protein and antigenic analysis. J Virol (1974) 1.76
Hamster ascitic fluids containing complement-fixing antibody against virus-induced tumor antigens. Proc Soc Exp Biol Med (1965) 1.74
Cloned human polyomavirus JC DNA can transform human amnion cells. J Virol (1980) 1.50
Persistent BK papovavirus infection of transformed human fetal brain cells. I. Episomal viral DNA in cloned lines deficient in T-antigen expression. J Virol (1979) 1.50
Biological and biochemical studies of African green monkey lymphotropic papovavirus. J Virol (1982) 1.46
Establishment of a cell line from an inbred mouse strain for viral transformation studies: simian virus 40 transformation and tumor production. J Natl Cancer Inst (1968) 1.40
Relationship between the methionine tryptic peptides of simian virus 40 and BK virus tumor antigens. J Virol (1977) 1.38
The colinear alignment of the genomes of papovaviruses JC, BK, and SV40. Virology (1979) 1.32
JC human papovavirus replication in human amnion cells. J Virol (1979) 1.28
Visna virus: a slow virus with an RNA dependent DNA polymerase. Nature (1971) 1.28
Immunochemical characterization of plaque mutants of simian virus 40. J Virol (1969) 1.28
Replication of polyoma virus in mouse embryo cells: electron microscopic observations. Virology (1966) 1.28
Polynucleotide sequences common to the genomes of simian virus 40 and the human papovaviruses JC and BK. Virology (1976) 1.25
Complementation between BK human papovavirus and a simian virus 40 tsA mutant. J Virol (1976) 1.24
SV40 thermosensitive mutant: synthesis of viral DNA and virus-induced proteins at nonpermissive temperature. Virology (1970) 1.23
Physical and biochemical properties of progressive pneumonia virus. J Virol (1971) 1.23
Heat-labile serum factor required for immunofluorescence of polyoma tumor antigens. Science (1966) 1.22
Electron microscopic observations on multiple polyoma virus-related particles. Virology (1967) 1.17
Characterization of JC papovavirus adapted to growth in human embryonic kidney cells. J Virol (1980) 1.17
Antigenic and morphological similarities of progressive pneumonia virus, a recently isolated "slow virus" of sheep, to visna and maedi viruses. J Virol (1971) 1.17
Transformation of murine cells by two "slow viruses," visna virus and progressive pneumonia virus. J Virol (1971) 1.13
Lymphotropic papovavirus transformation of hamster embryo cells. J Virol (1984) 1.11
Transformation of mouse cells by K-papovavirus. Virology (1970) 1.05
Isolation of simian virus 40 from rhesus monkeys (Macaca mulatta) with spontaneous progressive multifocal leukoencephalopathy. J Infect Dis (1977) 1.03
"Rescued" SV40: increased transforming efficiency in mouse and human cells. Proc Natl Acad Sci U S A (1969) 1.00
A new monkey lymphotropic papovavirus: characterization of the virus and evidence of a related virus in humans. Prog Clin Biol Res (1983) 1.00
Hamster tumor cells doubly transformed by SV40 and polyoma viruses. Virology (1966) 0.98
Characterization of the genome of the murine papovavirus K. J Virol (1979) 0.98
Immune response in the hamster. VI. Antibody response in polyoma oncogenesis. J Natl Cancer Inst (1972) 0.97
Characterization of "heavy" and "light" SV40-like particles from a patient with PML. Virology (1974) 0.96
Transformation of mouse macrophages by simian virus 40. J Virol (1970) 0.95
Evaluation of normal and neoplastic human tissue for BK virus. Virology (1978) 0.93
Alignment of the genome of monkey B-lymphotropic papovavirus to the genomes of simian virus 40 and BK virus. J Virol (1983) 0.93
RACK permitting efficient handling of tissue cultures. Appl Microbiol (1966) 0.91
Phenotype of polyoma-induced hamster tumor cells lines. J Virol (1980) 0.91
Helper function for adenovirus replication in monkey cells by BK human papovavirus. Virology (1979) 0.90
Characterization of K virus and its comparison with polyoma virus. J Virol (1978) 0.90
Identification of B-lymphotropic papovavirus-coded proteins. J Virol (1983) 0.89
Transformation of rabbit kidney cells by BKV(MM) human papovavirus. Int J Cancer (1977) 0.88
Two defective DNAs of human polyomavirus JC adapted to growth in human embryonic kidney cells. J Virol (1982) 0.88
Expression of various tumor-specific antigens in polyoma virus-induced tumors. Cancer Res (1972) 0.87
Biochemical properties of a hamster syncytium-forming ("foamy") virus. J Natl Cancer Inst (1975) 0.86
The resistance of SV40-transformed 3T3 to supertransformation. Proc Soc Exp Biol Med (1971) 0.85
Non-heritable interferon resistance in a fraction of virus populations. Proc Soc Exp Biol Med (1966) 0.85
Monkey B-lymphotropic papovavirus mutant capable of replicating in T-lymphoblastoid cells. J Virol (1985) 0.84
Immunofluorescent studies of mouse and hamster cell surface antigens induced by polyoma virus. J Natl Cancer Inst (1968) 0.84
Properties of simian virus 40 and BK virus tumor antigens form productively infected and transformed cells. Virology (1978) 0.83
Polyoma virus-human cell interactions: persistence of T-antigen in two cell lines with and without transformation. J Virol (1978) 0.80
Induction of simian virus 40 (SV40) transplantation immunity in mice by SV40-transformed cells of various species. J Natl Cancer Inst (1977) 0.79
Increased transformation efficiency of Simian virus 40 in rat embryo cells infected with Rauscher leukaemia virus. Nat New Biol (1971) 0.79
Comparative studies on Visna, progressive pneumonia, and Rous sarcoma viruses by electron microscopy. J Natl Cancer Inst (1973) 0.78
Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice. Int J Cancer (1978) 0.77
Accelerated transformation by polyoma virus in rat embryo cells infected with Rauscher Leukemia virus. Proc Soc Exp Biol Med (1971) 0.77
Analysis of T antigen and viral DNA in mouse cells transformed by K virus, a nononcogenic murine papovavirus. J Virol (1984) 0.75
High-titer SV40 replication in human fibroblast cell lines derived from patients with Wiskott-Aldrich syndrome. Virology (1983) 0.75
Human papovaviruses: current knowledge on their biologic and oncogenic properties. Bibl Haematol (1975) 0.75
Brief communication: specific transplantation antigens of murine neoplasms induced by visna and progressive pneumonia viruses. J Natl Cancer Inst (1973) 0.75
Human papovaviruses. Int Rev Exp Pathol (1978) 0.75
Expression of a new complement-fixing antigen reactive with murine sarcoma virus rat antiserum in rat cells transformed by polyoma virus. Nat New Biol (1972) 0.75
In vitro carcinogenesis studies: dual effect of RNA tumor viruses and carcinogenic chemicals or DNA viruses. Bibl Haematol (1973) 0.75